Recent advances in our understanding of the biology of breast cancer have made it clear
that LABC does not represent a single clinical entity but rather a heterogeneous group of …

Background The new “prognostic stage” in the 8th edition of the American Joint Committee
on Cancer (AJCC) incorporated important biologic factors such as estrogen receptor (ER) …

PURPOSE Neoadjuvant chemotherapy (NAC) is used to treat locally advanced breast
cancer (LABC) and high-risk early breast cancer (BC). Pathological complete response …

Background: The authors examined the safety of a protocol for planned skin-preserving
delayed breast reconstruction after postmastectomy radiotherapy with placement of a tissue …

We read the article “Concurrent chemoradiotherapy for locally advanced breast cancer—
time for a new paradigm?” by Mandilaras et al. 1 with great interest. The authors stated that …

Introduction MicroRNAs (miRNAs) are small non-coding RNA that plays a vital role in cancer
progression. Neo-adjuvant chemotherapy (NAC) has become the standard of care for locally …

Background: Former studies have shown that extract from American ginseng (Panax
quinquefolius) may possess certain antiproliferative effects on cancer cells. In this study, the …

Background Surgical ablation for locally advanced breast cancer results in large chest wall
defects, which can then be managed with local flaps or skin grafts. The purpose of this article …

Objective To evaluate the accuracy of CESM technique in predicting the final pathological
response and residual tumor size post NAC in LABC. Patients and methods This study was …

Introduction Neoadjuvant chemotherapy has become the standard of care for the diverse
population of women diagnosed with locally advanced breast cancer. Serum biomarker …